The FDA just authorized the first pill to treat COVID-19, replenishing the toolkit of treatments against Omicron Andrew Dunn, Allison DeAngelis 22 dec 2021
Premium An MIT professor thinks he’s found biotech’s holy grail. If he’s right, it could save drug companies billions Allison DeAngelis 15 dec 2021
As gene-editing moves mainstream, a pioneer in the field is testing whether it could prevent Alzheimer’s Allison DeAngelis 22 nov 2021
Blood tests that can detect cancer are about to hit the market. But experts are still waiting to see if they can upend deadly disease. Allison DeAngelis 20 okt 2021
Experts are raising questions about Biden’s COVID-19 booster shot strategy Allison DeAngelis 19 aug 2021
Apps and video games are changing the way we treat diseases. Experts say they’re prime M&A targets for telehealth firms. Allison DeAngelis 21 jul 2021
The head of the FDA is calling for an investigation into her agency’s controversial decision to approve a new Alzheimer’s drug Allison DeAngelis 09 jul 2021
The FDA approved a controversial, $56,000-a-year Alzheimer’s drug despite opposition inside the agency, internal memos show Allison DeAngelis 22 jun 2021
Premium Waarom het vrijgeven van patenten voor coronavaccins niet gaat helpen om de productie te versnellen Allison DeAngelis, Business Insider Nederland 08 mei 2021
